Scroll To Top

Docs Cool to Wide Distribution of PrEP

Docs Cool to Wide Distribution of PrEP


Despite initial positive reaction to the pill Truvada, which looked to be a way to hinder HIV infection, doctors now say they are hesitant to prescribe the expensive drug to otherwise healthy people because it might cause severe nausea and kidney damage.

Bloomberg News reports that while the breakthrough was significant for those looking to prevent HIV transmission or slow down its manifestation, the drug is costly (about $12,000 annually or $35 per pill), and doctors say more research must be done on the pill, which is known as PrEP.

“This may be the most important scientific breakthrough we’ve had so far to date that we don’t know what to do with,” Kevin Robert Frost, chief executive officer of the New York-based Foundation for AIDS Research, said in the article. “At the end of the day this study may prove valuable for the proof of concept that it represents and not for any specific application.”

A November study published in the New England Journal of Medicine shows that HIV-negative men who took Truvada regularly were 92% less likely to become infected with the virus. The study showed that overall, the pill cut the rate of infection by 44% in 2,500 gay men who were preventatively taking the pill for up to three years.

Out Subscription Lil Nas XAdvocateChannel promotion

From our Sponsors

Most Popular

Fifth Person Cured of HIV

Be sure to follow Plus on your favorite social platforms!


Want more news, top stories, and videos? Check out the all NEW Advocate Channel!
Your 24/7 streaming source for equality news and lifestyle trends.
Click this link right now:

Latest Stories